ExodusPoint Capital Management’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$646K	Buy	+59,253	New	+$740K	0.01%	1121
2025 Q4	–	Sell	-83,486	Closed	-$1.08M	–	1931
2025 Q3	$1.08M	Buy	+83,486	New	+$1.12M	0.02%	942
2024 Q4	–	Sell	-415,113	Closed	-$6.49M	–	1913
2024 Q3	$6.49M	Buy	415,113 +338,808	+444%	+$6.14M	0.07%	325
2024 Q2	$1.31M	Sell	76,305 -156,406	-67%	-$2.75M	0.01%	931
2024 Q1	$3.64M	Buy	232,711 +50,472	+28%	+$742K	0.05%	491
2023 Q4	$2.72M	Buy	182,239 +32,111	+21%	+$430K	0.03%	488
2023 Q3	$2.42M	Buy	150,128 +138,666	+1,210%	+$4M	0.03%	617
2023 Q2	$476K	Buy	+11,462	New	+$712K	0.01%	1382
2022 Q3	–	Sell	-33,303	Closed	-$2.31M	–	2167
2022 Q2	$2.31M	Buy	+33,303	New	+$2.51M	0.03%	724
2022 Q1	–	Sell	-18,975	Closed	-$1.43M	–	2540
2021 Q4	$1.43M	Buy	18,975 +9,816	+107%	+$985K	0.02%	899
2021 Q3	$1.06M	Buy	9,159 +4,234	+86%	+$640K	0.02%	994
2021 Q2	$1.09M	Buy	+4,925	New	+$958K	0.02%	965
2021 Q1	–	Sell	-29,054	Closed	-$5.03M	–	2466
2020 Q4	$5.03M	Sell	29,054 -28,335	-49%	-$3.88M	0.08%	246
2020 Q3	$6.39M	Sell	57,389 -13,430	-19%	-$1.07M	0.19%	145
2020 Q2	$4.2M	Buy	70,819 +51,663	+270%	+$3.4M	0.12%	191
2020 Q1	$1.29M	Sell	19,156 -18,903	-50%	-$1.49M	0.11%	255
2019 Q4	$3.21M	Buy	38,059 +29,202	+330%	+$2.36M	0.09%	235
2019 Q3	$662K	Buy	+8,857	New	+$708K	0.03%	537